Analytical Data
-
基因名
TFF3
- Application
-
别名
TFF3；ITF；TFI；Trefoil factor 3
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q07654
-
表达区间
22-80aa
-
氨基酸序列
EEYVGLSANQ CAVPAKDRVD CGYPHVTPKE CNNRGCCFDS RIPGVPWCFK PLQEAECTF
-
分子量
6.6 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TFF3 (Trefoil Factor 3) is a member of the trefoil factor family, which is known for its role in gastrointestinal mucosal protection and repair. It is predominantly expressed in the intestinal epithelium and has been implicated in various physiological processes, including wound healing, cell migration, and maintaining mucosal integrity. Dysregulation of TFF3 has been associated with several gastrointestinal disorders, including inflammatory bowel diseases and cancer. Research into recombinant TFF3 protein aims to elucidate its biological functions and therapeutic potential. By producing TFF3 in a recombinant form, researchers can investigate its mechanisms of action in mucosal healing and repair, assess its role in epithelial cell behavior, and explore its promise as a biomarker or therapeutic target. Additionally, understanding the structural features of TFF3 through recombinant technology may pave the way for the development of novel drugs designed to enhance mucosal healing or target specific pathways in disease contexts. Overall, the study of recombinant TFF3 protein holds significant promise for advancing our understanding of gastrointestinal health and disease, as well as developing innovative therapeutic strategies for related conditions.
